🇺🇸 FDA
Patent

US 11247971

Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

granted A61KA61K31/415A61K31/4155

Quick answer

US patent 11247971 (Small molecule inhibitors of lactate dehydrogenase and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/415, A61K31/4155, A61K31/4178, A61K31/422